Prostate Cancer Conference ‘20/20 and...

3
‘20/20 and Beyond’ Prostate Cancer Conference 6th, 7th, 8th of September, 2019 New Westminster, BC The BC Support Group Council invites you to join them

Transcript of Prostate Cancer Conference ‘20/20 and...

Page 1: Prostate Cancer Conference ‘20/20 and Beyond’prostatecancerbc.ca/images/2019-conference-master-715.pdf‘20/20 and Beyond’ Prostate Cancer Conference 6th, 7th, 8th of September,

‘20/20 and Beyond’

Prostate Cancer Conference

6th, 7th, 8th of September, 2019New Westminster, BC

The BCSupportGroup

Council invites you to

join them

Page 2: Prostate Cancer Conference ‘20/20 and Beyond’prostatecancerbc.ca/images/2019-conference-master-715.pdf‘20/20 and Beyond’ Prostate Cancer Conference 6th, 7th, 8th of September,
Page 3: Prostate Cancer Conference ‘20/20 and Beyond’prostatecancerbc.ca/images/2019-conference-master-715.pdf‘20/20 and Beyond’ Prostate Cancer Conference 6th, 7th, 8th of September,

Don’t miss the knowledge, comraderie and laughs...it’s going to be great!

ContactsProstate Cancer Foundation BC#4 17918 55th AvenueSurrey BC V3S 6C8 604-574-4012

[email protected]

Sponsors, Supporting Organizations


Teaching LDR Prostate Brachytherapy · Teaching LDR Prostate Brachytherapy Prostate Cancer Institute NUI Galway experience ... • Project: 3D print individual prostate model for

Teaching LDR Prostate Brachytherapy · Teaching LDR Prostate Brachytherapy Prostate Cancer Institute NUI Galway experience ... • Project: 3D print individual prostate model for

The role of glycans in prostate cancer development and progressioneprint.ncl.ac.uk/file_store/production/219656/18A451F0-3... · 2016. 5. 20. · prostate cancer patients. However,

The role of glycans in prostate cancer development and progressioneprint.ncl.ac.uk/file_store/production/219656/18A451F0-3... · 2016. 5. 20. · prostate cancer patients. However,

VALUE-BASED HEALTHCARE STRATEGIES for better prostate … · 2017-03-20 · VALUE-BASED HEALTHCARE STRATEGIES for better prostate cancer outcomes Frank Sullivan MB MRCPI FFRRSCI Adjunct

VALUE-BASED HEALTHCARE STRATEGIES for better prostate … · 2017-03-20 · VALUE-BASED HEALTHCARE STRATEGIES for better prostate cancer outcomes Frank Sullivan MB MRCPI FFRRSCI Adjunct

Localised High Risk Prostate Cancer: Oncological and functional … · 2013-07-20 · Localised High Risk Prostate Cancer: Oncological and functional outcomes ... Around 30% of diagnosed

Localised High Risk Prostate Cancer: Oncological and functional … · 2013-07-20 · Localised High Risk Prostate Cancer: Oncological and functional outcomes ... Around 30% of diagnosed

PROSTATE CANCER PATIENT GUIDE · 2018-01-23 · IS THERE A CURE FOR PROSTATE CANCER? ... to all incurable prostate cancer. Prostate cancer is 100% ... PROSTATE CANCER PATIENT GUIDE

PROSTATE CANCER PATIENT GUIDE · 2018-01-23 · IS THERE A CURE FOR PROSTATE CANCER? ... to all incurable prostate cancer. Prostate cancer is 100% ... PROSTATE CANCER PATIENT GUIDE

Immunohistochemistry in Prostate Pathology Revie immun -prostate-pathology.pdf · IHC Prostate Pathology 4 Prostate Cancer Prostate cancer is the second most common cancer in men

Immunohistochemistry in Prostate Pathology Revie immun -prostate-pathology.pdf · IHC Prostate Pathology 4 Prostate Cancer Prostate cancer is the second most common cancer in men

Benign Prostate Hyperplasia & Prostate Cancer

Benign Prostate Hyperplasia & Prostate Cancer

Castration-Resistant Prostate Cancer (CRPC): evaluation of ... · What is CRPC? •Castration-Resistant Prostate Cancer •10 – 20% of patients with PCa progress to CRPC •Canadian

Castration-Resistant Prostate Cancer (CRPC): evaluation of ... · What is CRPC? •Castration-Resistant Prostate Cancer •10 – 20% of patients with PCa progress to CRPC •Canadian

Prostate Cancer Screening - OSU Center for Continuing ... on Prostate Cancer Screening - 2.pdf · prostate-specific antigen-based screening. ... Goteborg Randomized Prostate Cancer

Prostate Cancer Screening - OSU Center for Continuing ... on Prostate Cancer Screening - 2.pdf · prostate-specific antigen-based screening. ... Goteborg Randomized Prostate Cancer

Activated a2macroglobulin binding to human prostate cancer ... · 2/26/2015  · prostate cancer (20-23), where it functions as a very high affinity 2M* signaling receptor linked

Activated a2macroglobulin binding to human prostate cancer ... · 2/26/2015  · prostate cancer (20-23), where it functions as a very high affinity 2M* signaling receptor linked

Prostate Cancer Risk Calculator - pliszka.netpliszka.net/uro-files/2013/prezentacje/11-sosnowski.pdf · 2013-08-20 · ERSPC prostate cancer risk calculator ... Case 1 • DRE - BPH

Prostate Cancer Risk Calculator - pliszka.netpliszka.net/uro-files/2013/prezentacje/11-sosnowski.pdf · 2013-08-20 · ERSPC prostate cancer risk calculator ... Case 1 • DRE - BPH

Advances in Brachytherapy for Prostate Cancerpliszka.net/uro-files/2013/prezentacje/12-zelefsky.pdf · 2013-08-20 · Prostate Cancer Brachytherapy 2013 •Careful selection of patients

Advances in Brachytherapy for Prostate Cancerpliszka.net/uro-files/2013/prezentacje/12-zelefsky.pdf · 2013-08-20 · Prostate Cancer Brachytherapy 2013 •Careful selection of patients

Prostate Segmentation Challenge and MR-guided Prostate Biopsy

Prostate Segmentation Challenge and MR-guided Prostate Biopsy

Prostate cancer Tim Bracey Histopathology. Prostate cancer What are we going to talk about? Anatomy of prostate Anatomy of prostate Very basic histology!

Prostate cancer Tim Bracey Histopathology. Prostate cancer What are we going to talk about? Anatomy of prostate Anatomy of prostate Very basic histology!

Prostate Cancer Screening 9-30-20...2020/09/30  · Digital Rectal Exam 17 Prostate Cancer Screening: Digital Rectal Exam •Early cancers (T1) not palpable •Positive DRE = ninefold

Prostate Cancer Screening 9-30-20...2020/09/30  · Digital Rectal Exam 17 Prostate Cancer Screening: Digital Rectal Exam •Early cancers (T1) not palpable •Positive DRE = ninefold

Evaluation of placental prostate specific antigen, estradiol and … · 2020-06-20 · Evaluation of placental prostate specific antigen, estradiol and interleukin-6 and their significance

Evaluation of placental prostate specific antigen, estradiol and … · 2020-06-20 · Evaluation of placental prostate specific antigen, estradiol and interleukin-6 and their significance

NY Prostate Cancer Conference - A. Stephenson - Session 4: Predicting clinical and biochemical endpoints after surgery

NY Prostate Cancer Conference - A. Stephenson - Session 4: Predicting clinical and biochemical endpoints after surgery

Supplementary Information for - PNAS · 2018-04-20 · Fig. S3. Expression of candidate PrAd and NEPC cell surface antigens in prostate cancer and benign prostate gene expression

Supplementary Information for - PNAS · 2018-04-20 · Fig. S3. Expression of candidate PrAd and NEPC cell surface antigens in prostate cancer and benign prostate gene expression

Prostate Pathology. Prostate weighs 20 grams in normal adult Retroperitoneal organ,encircling the neck of bladder and urethra Devoid of a distinct capsule.

Prostate Pathology. Prostate weighs 20 grams in normal adult Retroperitoneal organ,encircling the neck of bladder and urethra Devoid of a distinct capsule.

Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason

Prostate Cancer Grading - Pathology · 67 Pathology Experts in Prostate Cancer from 21 Countries 20 Urology, Oncology, and Radiation Oncology Experts. Reporting Rules for Gleason